FDA Inspection
Owen Biosciences Inc.Owen Biosciences Inc. – FDA Inspection, Sep 14, 2016
Record Details
This FDA Inspection record concerns Owen Biosciences Inc., with an inspection on September 14, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Owen Biosciences Inc.
- Inspection Date
- September 14, 2016
- Product Type
- Drugs
View Company Profile
ID · ba52a3d4-4270-4d04-a929-b8ea80f03423
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 985050
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.166(b)Accelerated stability studies
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.160(b)(4)Test devices not meeting specifications
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Owen Biosciences Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| March 27, 2025 | OAI | New Orleans District Office | Drug Quality Assurance |
| February 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2011 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Owen Biosciences Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.